Please Wait
Applying Filters...

Annual Sales of Prestwick3_000493 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 51Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Losec/Prilosec

02 1Zegerid

PharmaCompass

01

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 263

Growth (%) : -30

blank

02

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2021 Revenue in Millions : 180

2020 Revenue in Millions : 183

Growth (%) : -2

blank

03

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2015 Revenue in Millions : 422

2014 Revenue in Millions : 340

Growth (%) : -19%

blank

04

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 271

2016 Revenue in Millions : 276

Growth (%) : -2

blank

05

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2014 Revenue in Millions : -13.20%

2013 Revenue in Millions :

Growth (%) :

blank

06

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 272

2017 Revenue in Millions : 271

Growth (%) : 0%

blank

07

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 276

2015 Revenue in Millions : 340

Growth (%) : -19

blank

08

Brand Name : Losec/Prilosec

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Losec/Prilosec

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 263

2018 Revenue in Millions : 272

Growth (%) : -3

blank

09

Brand Name : Zegerid

Omeprazole

arrow
AAPS 2024
Not Confirmed

Brand Name : Zegerid

arrow
AAPS 2024
Not Confirmed

Omeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 98

2015 Revenue in Millions : Not Reported

Growth (%) : Not Reported

blank